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Introduction
Cell migration is critical for many physiological processes
such as gastrulation and wound healing, and misregulation
of migration can contribute to tumor metastasis and
cardiovascular disease. Cortactin is a cytoskeletal protein
that regulates cell migration in response to a number of
extracellular stimuli (Weed and Parsons, 2001). It was initially
identified as a target of the oncogenic tyrosine kinase, v-src,
and the human gene, EMS1, is amplified in 13% of breast
cancers and 29% of head and neck tumors (Kanner et al., 1990;
Wu et al., 1991; Schuuring et al., 1992). Overexpression of
cortactin both in tumorigenic and non-tumorigenic cell lines
leads to increased cellular motility and invasiveness (Okamura
and Resh, 1995; Huang et al., 1998; Patel et al., 1998; Bowden
et al., 1999). These phenotypes may be related to the
localization of cortactin at sites of actin rearrangement where
it regulates actin dynamics (Wu and Parsons, 1993; Kaksonen
et al., 2000; Weed et al., 2000; Uruno et al., 2001; Weaver et
al., 2001).
Cortactin is composed of a series of modular domains that
mediate interactions with a variety of binding partners (Fig.
1A) (Wu and Parsons, 1993; Weed and Parsons, 2001). In vitro,
the N-terminal half of cortactin (amino acids 1-326) binds to
F-actin and induces actin filament assembly through activation
of the Arp2/3 complex, a major cellular regulator of de novo
actin polymerization (Welch et al., 1998; Uruno et al., 2001;
Weaver et al., 2001). Isolated Arp2/3 complex is inactive
unless activated by nucleation promoting factors (Pollard and
Borisy, 2003). Once activated, Arp2/3 complex binds the side
of a pre-existing actin filament and generates a new filament
as a 70° branch (Amann and Pollard, 2001).
WASP family proteins, including WASP, N-WASP and
Scar/WAVE, are potent activators of the Arp2/3 complex. The
WH2-Acidic (WA) domain of WASP proteins binds the Arp2/3
complex through an acidic motif and G-actin via a WH2
domain (Machesky and Insall, 1998; Egile et al., 1999; Higgs
et al., 1999). Formation of a ternary complex between the WA
domain, an actin monomer and the Arp2/3 complex promotes
a conformational change that leads to its activation (Higgs and
Pollard, 2001).
Cortactin, which binds Arp2/3 complex through the N-
terminal acidic region (NTA) and F-actin through the repeat
region, is thought to activate the Arp2/3 complex by enhancing
its interaction with the sides of actin filaments (Weed et al.,
2000; Uruno et al., 2001; Weaver et al., 2001). As the cortactin
N-terminus is sufficient for both its ability to activate Arp2/3
and targeting cortactin to sites of actin assembly at the leading
edge, the C-terminal half of cortactin (amino acids 327-546)
was thought to be of little importance in the regulation of actin
reorganization. However, recent studies show that the cortactin
SH3 domain interacts with several regulators of the actin
machinery, including dynamin, WASP-interacting protein
(WIP) and N-WASP (McNiven et al., 2000; Mitzutani et al.,
2002; Kinley et al., 2003).
Isolated N-WASP exists in an autoinhibited conformation,
in which the WA domain is rendered inaccessible.
This autoinhibition can be relieved by binding of
phosphatidylinositol 4,5-bisphosphate (PIP2) and Cdc42-GTP
to the basic region and CRIB domain of N-WASP, respectively
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Cortactin is an actin-associated scaffolding protein that
regulates cell migration. Amplification of the human gene,
EMS1, has been detected in breast, head and neck tumors,
where it correlates with increased invasiveness. Cortactin
can regulate actin dynamics directly via its N-terminal half,
which can bind and activate the Arp2/3 complex. The C-
terminal portion of cortactin, however, is thought to
have limited function in its regulation of the actin
polymerization machinery. In this report, we identify a role
for the cortactin C-terminus in regulating cell migration
and, more specifically, actin dynamics. Overexpression of
either full-length cortactin or cortactin C-terminus is
sufficient to enhance migration of mammary epithelial
cells. In vitro, cortactin binds to and activates, via its SH3
domain, a regulator of the Arp2/3 complex, neural Wiskott
Aldrich Syndrome protein (N-WASP). This in vitro
activation of N-WASP is likely to be important in vivo, as
cortactin-enhanced migration is dependent upon N-WASP.
Thus, our results suggest that cortactin has multiple
mechanisms by which it can recruit and modulate the actin
machinery and ultimately regulate cell migration.
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(Higgs and Pollard, 2000; Prehoda et al., 2000; Rohatgi et al.,
2000). SH3 domain-containing adaptor proteins, such as Nck
and Grb2, can also activate N-WASP through binding to the
proline-rich region (Carlier et al., 2000; Rohatgi et al., 2001).
Activation of N-WASP thus unmasks the WA domain, which
binds and activates the Arp2/3 complex (Egile et al., 1999; Kim
et al., 2000; Rohatgi et al., 2000; Higgs and Pollard, 2001).
Given that (1) cortactin and N-WASP colocalize in
podosomes; (2) the cortactin SH3 domain binds N-WASP; and
(3) other SH3 domain-containing proteins can activate N-
WASP, we tested whether the cortactin C-terminus can regulate
cellular actin-based processes, specifically cell migration,
through activation of N-WASP (Carlier et al., 2000; Rohatgi et
al., 2001; Mituzani et al., 2002). Our results demonstrate that
expression of cortactin C-terminus enhances the migration of
mouse mammary epithelial cells in an SH3-dependent manner;
and, in vitro, the cortactin SH3 domain stimulates Arp2/3-
mediated actin polymerization via activation of N-WASP. This
interaction is important for actin-based processes in cells, as
cortactin-enhanced migration requires N-WASP.
Materials and Methods
Cell culture
SCp2 cells were grown in DMEM/F12 supplemented with 2% fetal
bovine serum (FBS), 5 µg/ml insulin and penicillin/streptomycin
(Desprez et al., 1993). N-WASP null (NW–/–) and rescued mouse
embryonic fibroblasts (MEFs) were cultured in DMEM containing
10% FBS and 1% penicillin/streptomycin (Snapper et al., 2001).
For generation of cortactin-expressing lines, SCp2 cells, NW–/– or
rescued MEFs were infected twice with pBABE retrovirus encoding
hemagglutinin (HA)-tagged full-length (FL), HA-Ct, HA-CtW525L
(C-terminus with W525L mutation) cortactin or vector only (V) as a
control (Morgenstern and Land, 1990). Infected cells were selected in
puromycin and the polyclonal puromycin-resistant population assayed
as described below. Expression of the HA-tagged proteins and
endogenous cortactin were analyzed by western blotting with anti-
HA.11 mAb (1:1000 dilution; Covance, Princeton) and anti-cortactin
4F.11 mAb (1:1000 dilution; Upstate Biotechnologies, Lake Placid).
Migration assays
Cell migration was assayed as described previously (Hagel et al.,
2002). Briefly, a confluent monolayer of cells was scratched with a
pipette tip to make two or three independent wounds for each sample
and placed in growth media containing 2% serum. Phase images of
each wound (10× magnification) were taken at 0 hours and at various
times after wounding. Care was taken to photograph the wound in the
same region at each time point. Wound area at each time point was
measured using NIH Image software. The change in wound area (area
at x hours – area at 0 hours) for each independent wound was
determined and an average change in area calculated for the sample.
Fold change in area=average change in area of sample cells / average
change in area of control cells. The statistical significance of the data
was determined by performing one-tailed paired t-tests using the
Prism software program. Differences in migration were considered
significant if P<0.05.
Protein purification
Actin was purified from rabbit muscle and isolated as Ca2+-ATP-G-
actin in G buffer (5 mM Tris-Cl, pH 7.8, containing 0.1 mM CaCl2,
0.2 mM ATP and 1 mM DTT) as described (Pardee and Spudich,
1982) and pyrenyl or rhodamine labeled. Bovine Arp2/3 complex was
purified from brain extracts as described (Egile et al., 1999). His6-
GST-N-WASP (GST-N-WASP) and His6-N-WASP were expressed in
insect cells and purified on glutathione-sepharose and/or Ni2+-NTA
agarose as described (Egile et al., 1999; Rohatgi et al., 2000). GST-
cortactin proteins and GST-Nck were expressed in Escherichia coli
and affinity purified on glutathione-sepharose beads using standard
protocols. Cleavage of the GST tags from the cortactin C-terminus
and SH3 proteins where described was performed using bovine
thrombin protease (Sigma).
GST pull-down assays
GST fusions of cortactin variants were immobilized on glutathione
beads. Equivalent amounts of each fusion protein (225 pmol) were
incubated with 800 µg NIH3T3 cell lysate in lysis buffer (20 mM Tris,
pH 7.4, 0.1 M NaCl, 1 mM EDTA, 1% NP-40, 10% glycerol) for 1
hour at 4°C, then washed five times with lysis buffer. Bound proteins
were eluted in sample buffer, resolved by SDS-PAGE and probed with
an anti-N-WASP antibody (gift of H. Ho and M. Kirschner, Harvard
Medical School). For peptide competition assays, ~700 pmol GST-
SH3 protein bound to glutathione beads was pre-incubated with the
indicated concentrations of ‘cortoptimal’ or ‘control’ peptide (see
below) for 10 minutes at 25°C prior to incubation with 200 µg
NIH3T3 cell lysate.
Pyrene actin polymerization assays
Pyrene actin assays were performed essentially as described (Amann
and Pollard, 2001). Briefly, GST-cortactin fusion proteins and GST-
N-WASP or His6-N-WASP (25 nM) were added to purified bovine
Arp2/3 complex (10 nM) in KMET buffer (50 mM KCl, 1 mM MgCl2,
1 mM EGTA, 10 mM Tris, pH 7.0, 0.5 mM ATP and 1 mM DTT) at
25°C. Actin polymerization was initiated by the addition 1.5 µM G-
actin (5-10% pyrene labeled) and monitored by continuous pyrene
fluorescence measurements (λex=386 nm, λem=407 nm) (Cooper et al.,
1983; Mullins et al., 1998). Fold activation=maximum polymerization
rate (GST-protein+N-WASP) / maximum polymerization rate
(N-WASP). Fold activation curves represent a logarithmic ‘best-fit’ of
the data points. Maximum polymerization rates were taken as
the slope of the linear phase of each polymerization curve and
represent the average of two to three experiments. For peptide
inhibition experiments, a 16 amino acid peptide (‘cortoptimal’:
LGEFSKPPIPQKPTWM) or a random 14 amino acid peptide
(‘control’: GGNFAPQLSYGYDE) was pre-incubated with 500 nM
GST-SH3 for 5 minutes at 25°C prior to use with GST-N-WASP and
bovine Arp2/3 complex in the pyrene-actin assay.
Results
Overexpression of cortactin enhances the migration and
invasiveness of both normal and malignant cells (Okamura and
Resh, 1995; Huang et al., 1998; Patel et al., 1998; Bowden et
al., 1999). As the N-terminal half of the molecule can bind and
activate the Arp 2/3 complex, it is generally presumed that
cortactin regulates migration via this pathway (Weed et al.,
2000; Uruno et al., 2001; Weaver et al., 2001). The C-terminal
half of cortactin, however, also interacts with several proteins
that are linked to the actin polymerization machinery
(McNiven et al., 2000; Mitzutani et al., 2002; Kinley et al.,
2003). To investigate the importance of the cortactin C-
terminus in cell motility, we expressed full-length cortactin or
cortactin C-terminus (amino acids 324-546) in the SCp2 mouse
mammary epithelial cell line and tested the ability of these cells
to migrate in wound healing assays (Fig. 1). After 15 hours,
the wound area closed in cells expressing either full-length
cortactin or cortactin C-terminus was twofold greater than that
Journal of Cell Science 118 (1)
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observed in control cells (Fig. 1C,D compare cortactin variant
infected cells to control infected cells). Similar results were
also observed with expression of the N-terminal half alone
(amino acids 1-326; data not shown). In addition, when SCp2
cells expressing these different cortactin variants were cultured
in a 3-dimensional matrix, differentiation was disrupted (S.G.
and S.M.T., unpublished). The migration results do not reflect
any differences in the number of cell divisions, as no significant
differences in the proliferative rates of the cells were observed
and differences in wound closure were detected as early as 6-
8 hours. Interestingly, the ability of cortactin C-terminus to
enhance cell migration requires an intact SH3 domain, as
mutation of a critical residue in the SH3 binding pocket
strongly inhibited this effect (Fig. 1C,D).
Although the ability of the N-terminal half to bind and
activate Arp2/3 complex may contribute to the cortactin-
induced migration, the mechanism by which cortactin C-
terminus enhances cell migration was unclear. Given that the
cortactin SH3 domain interacts with N-WASP, an activator of
the Arp2/3 complex, we hypothesized that the cortactin C-
terminus-enhanced migration could be mediated through its
ability to activate N-WASP.
As previously reported, cortactin full-length, C-terminus and
SH3 proteins interacted with N-WASP in GST pull-down
assays (Fig. 2A) (Mitzutani et al., 2002). Conversely, no N-
WASP bound to a cortactin SH3W525L mutant protein (inset
in Fig. 3D). Neither cortactin N-terminus nor GST alone
interacted with N-WASP, as expected (Fig. 2A) (Mitzutani et
al., 2002). To determine whether cortactin C-terminus binding
can activate N-WASP, in vitro pyrene-actin assembly assays
were performed with purified proteins (Fig. 2A-E) (Cooper et
al., 1983; Mullins et al., 1998).
In contrast to GST alone, GST-cortactin C-terminus (GST-
Ct) and GST-cortactin SH3 (GST-SH3) fusion proteins induced
up to six- and tenfold activation of GST-N-WASP, respectively
(Fig. 2B,C). These differing capacities for N-WASP activation
correlate with the abilities of each cortactin variant to bind N-
WASP, with GST-SH3 showing a roughly twofold higher
relative affinity for N-WASP compared to GST-Ct (data not
shown). At the concentrations of Arp2/3 complex used in these
Fig. 1. Overexpression of full-length or C-terminal cortactin enhances migration of mouse SCp2 mammary epithelial cells. (A) Domain
structure of cortactin variants used in this study. FL, full-length cortactin; Nt, N-terminal (1-326 amino acids) cortactin; Ct, C-terminal (324-
546 amino acids) cortactin; CtW525L, C-terminus of cortactin with W525L mutation; SH3, SH3 domain; SH3W525L, SH3 domain with
W525L mutation. (B) Expression of cortactin variants in SCp2 cells. Western blot showing expression of the HA-FL, HA-Ct and HA-CtW525L
cortactin (upper blot) or endogenous cortactin (lower blot). Constructs were expressed at or below the level of endogenous cortactin.
Arrowheads denote HA-FL, HA-Ct and HA-CtW525L bands. V, control vector expression. (C) Migration of SCp2 cells in a representative
wounding experiment is shown for control vector only infected (V) or cortactin variant infected (HA-FL, HA-Ct, HA-CTW525L) cells with
images at 0 and 15 hours. (D) Quantification of wound closure data from three to seven experiments. Fold change in wound area was calculated
as described in Materials and Methods. Error bars indicate s.e.m. and asterisks indicate statistically significant differences from change in area
calculated for control cells (P<0.05).
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experiments, none of the cortactin variants directly activated
Arp2/3 complex, thus all actin polymerization represents
effects on N-WASP (data not shown). Although Nck, an SH3-
containing adaptor, was a more robust activator of N-WASP
(17-fold), GST-Nck also precipitated an average of twofold
more N-WASP than did the cortactin fragments over a range
of concentrations (Fig. 2C, data not shown). Although it is
known that not all three of the Nck SH3 domains contribute
equally to N-WASP activation, the presence of all three
domains is required for both optimal binding to and activation
of N-WASP (Rohatgi et al., 2001). However, the single
cortactin SH3 domain can still activate N-WASP up to tenfold.
To rule out the possibility that activation of N-WASP by
cortactin was solely due to the GST tags present on both
the cortactin and N-WASP proteins, two complementary
experiments were performed. First, we used a His6-N-WASP
Journal of Cell Science 118 (1)
Fig. 2. The SH3 domain of cortactin is sufficient to activate N-WASP. (A) Western blot (left) of GST pull-down assays showing association of
GST-cortactin fusions with endogenous N-WASP. TCL, total cell lysate; 1/40th of the amount of lysate used in the pull down was used for
TCL. Right panel shows comparative size of GST fusion proteins used in this study on Coomassie-stained gels. Values down the side of the gel
show the positions of protein standards in kDa. (B-E) Pyrene Assays. 10 nM Arp2/3 complex, 1.5 µM pyrene-labeled G-actin and 25 nM GST-
N-WASP or His6-N-WASP were incubated together with GST-tagged or untagged cortactin proteins at the specified concentrations. (B) Optimal
activation of GST-N-WASP by GST-cortactin proteins (GST, 1.3 µM; GST-Ct, 1.3 µM; GST-SH3, 1 µM). (C) Fold activation of GST-N-WASP
by GST, GST-Ct or GST-SH3 cortactin, or GST-Nck. All fold activation curves are a logarithmic ‘best fit’ of the data points shown. Inset shows
N-WASP binding to GST-Ct, GST-SH3 and GST-Nck beads. (D) GST tag on N-WASP is not required for N-WASP activation by cortactin.
Sample polymerization curves are shown for each GST-cortactin protein at the concentration giving optimal N-WASP activation in the pyrene
assay (GST, 250 nM; GST-Ct, 1 µM; GST-SH3, 250 nM). (E) GST tag is not required for N-WASP activation by cortactin C-terminus. Plots
show fold activation of GST-N-WASP by GST, GST-Ct, untagged cortactin C-terminus (Ct) or buffer control (Buffer).
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protein with GST-cortactin in the pyrene-actin polymerization
assays (Fig. 2D). This His6-N-WASP protein has a high basal
activity, which is probably because of a partial unfolding and
loss of autoinhibition (data not shown) (Egile et al., 1999). In
fact, in our hands, the His6-N-WASP protein gives 5.5-fold
basal activation of the Arp2/3 complex, whereas basal
activation by GST-N-WASP is only 1.7-fold (data not shown).
Despite the elevated basal activity, GST-Ct and GST-SH3
cortactin still induced 1.6- to 1.8-fold activation of His6-N-
WASP, whereas GST alone did not activate His6-N-WASP
(Fig. 2D and data not shown). In addition, untagged cortactin
C-terminus promoted up to fivefold activation of GST-N-
WASP (Fig. 2E). Finally, untagged cortactin SH3 domain also
activated N-WASP up to 2.5-fold (Fig. 3C,D). Thus, although
the GST tag can enhance the ability of cortactin C-terminus
and cortactin SH3 to activate N-WASP, probably through
stabilization of protein folding or by promoting cortactin
multimerization, it is not required.
To examine directly the role of the SH3 domain in N-WASP
activation, we used blocking peptides and an SH3 domain
mutant in the pyrene actin polymerization assays (Fig. 3). The
optimal proline-rich sequence for binding the cortactin SH3
domain, which was identified by phage display
(+PPψPXKPXWL), was used to design a 16 amino acid
blocking peptide designated ‘cortoptimal’ (Sparks et al., 1996).
This peptide and a random control peptide were first tested for
Fig. 3. N-WASP activation requires an intact, accessible SH3 domain. (A,B) Peptide inhibition. Pyrene assays were performed with 10 nM
Arp2/3 complex, 1.5 µM pyrene-labeled G-actin, 25 nM GST-N-WASP and 0.5 µM GST-SH3 in the presence of peptide inhibitors at the
specified concentrations. (A) Activation of N-WASP by cortactin SH3 protein in the presence of 100 µM cortoptimal or 100 µM control
peptides. The inset shows a western blot of competitive GST pull-down assays showing association of GST-SH3 cortactin with endogenous N-
WASP in the presence of increasing concentrations (0, 25, 50, 100, 200, 500, 1000 µM, left to right) of cortoptimal or control peptide. (B) 100
µM cortoptimal and control peptides have no effect on N-WASP alone or on WA-mediated actin polymerization. (C,D) Mutation of the SH3
domain. Pyrene assays were performed with 10 nM Arp2/3 complex, 1.5 µM pyrene-labeled G-actin and 25 nM GST-N-WASP, in the presence
of either GST-tagged or untagged cortactin SH3 domain. (C) Sample polymerization curves showing maximal GST-N-WASP activation by 2.5
µM SH3 or SH3W525L. Inset shows sample polymerization curves of maximal GST-N-WASP activation by 0.75 µM GST, GST-SH3 or GST-
SH3W525L proteins. (D) Fold activation of GST-N-WASP in the presence of untagged cortactin SH3 and SH3W525L proteins over a range of
concentrations. Curves are a logarithmic ‘best fit’ of the data points shown. Inset shows GST pull-down assays for N-WASP binding performed
in the presence of GST, GST-SH3 or GST-SH3W525L beads.
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their ability to block the cortactin-N-WASP interaction, then
each was added along with the cortactin SH3 protein in the
pyrene-actin polymerization assays (Fig. 3A). Neither peptide
had any effect on actin polymerization mediated by N-WASP
alone or the active WA fragment of N-WASP (Fig. 3B).
However, addition of 100 µM cortoptimal peptide inhibited
up to 40% of the cortactin SH3 domain-induced N-WASP
activation and as much as 60% inhibition was observed at higher
concentrations of the peptide (Fig. 3A and data not shown). The
cortoptimal peptide also inhibited N-WASP binding to cortactin
in competitive pull-down assays (half-maximal inhibition ~100
µM peptide) (Fig. 3A, inset). In contrast, there was no inhibition
by the control peptide of N-WASP binding or activation.
Furthermore, a cortactin SH3W525L mutant deficient in N-
WASP binding was impaired in its ability to activate N-WASP
(Fig. 3C,D). Taken together, these data clearly indicate that an
intact SH3 domain is required for maximal N-WASP binding
and activation by cortactin.
To examine the role of cortactin and N-WASP binding in
actin filament formation further, we performed bead assays in
a reconstituted actin-based motility system composed of
purified proteins (Loisel et al., 1999; Wiesner et al., 2003). In
the presence, but not the absence, of N-WASP, actin assembly
followed by the appearance of actin comet tails was observed
at the surface of carboxylated beads coated with GST-SH3 or
GST-Ct (data not shown). In contrast, GST-SH3W525L-coated
beads were significantly impaired in generating actin tails (data
not shown). This ability of the SH3 domain to form actin
comets in an N-WASP-dependent manner demonstrates that
this domain is sufficient to promote actin tail formation through
N-WASP and supports a role for cortactin in N-WASP
recruitment and activation.
As shown in Fig. 1, expression of the cortactin C-terminus
induces migration and this correlates with the ability of this
region to bind to and activate N-WASP (Fig. 1C,D; Figs 2, 4).
Although loss of N-WASP has no significant effect on wound
closure (Snapper et al., 2001) (data not shown), it is still possible
that N-WASP may be important for cortactin-induced migration.
Significantly, we found that the ability of full-length and C-
terminal cortactin to enhance migration was largely dependent
upon N-WASP (Fig. 4). Whereas reconstituted N-WASP-
deficient mouse embryonic fibroblasts (MEFs) (‘rescue’ cells)
expressing full-length cortactin or cortactin C-terminus
enhanced wound closure (1.8- and 1.9-fold, respectively)
compared to control vector-infected MEFs, expression of full-
length cortactin or cortactin C-terminus in N-WASP-deficient
MEFs (NW–/– cells) did not enhance wound closure compared
to control or CtW525L-expressing N-WASP–/– cells (Fig. 4).
Journal of Cell Science 118 (1)
Fig. 4. Maximal cortactin-enhanced migration requires N-WASP. (A) Western blot showing expression of the HA-FL, HA-Ct and HA-
CtW525L cortactin (upper blot) or endogenous cortactin (lower blot) in NW–/– or rescued MEFs. Arrowheads indicate HA-FL cortactin.
Expression of all HA-tagged constructs was equivalent to or less than endogenous cortactin levels. UI, uninfected cells. (B) HA-tagged, or in
some assays GFP-tagged, cortactin-expressing cells were assayed for wound closure at 0, 2, 4 and 6 hours after wounding. Data are the average
of four to five experiments at the 6-hour time point±s.e.m. Asterisks indicate statistically significant differences from wound closure results in
control cells (P<0.05). (C) Representative results from wounding assay experiments are shown with images taken at 0 and 6 hours after
wounding. The fold change in wound area is indicated underneath each figure.J
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These effects are unlikely to be due to expression differences, as
the full-length protein was expressed at equivalent levels in both
the N-WASP null and rescued MEFs, and cortactin C-terminus
was always expressed at higher levels in the N-WASP null cells
(Fig. 4A). Taken together, these data demonstrate that N-WASP
is necessary for maximal migration induced by either full-length
cortactin or cortactin C-terminus.
Discussion
It was previously thought that cortactin functions to recruit N-
WASP to sites of Arp2/3 localization (Mitzutani et al., 2002). In
this study, however, we show that the cortactin C-terminus, via
the SH3 domain, can directly stimulate the activity of N-WASP.
Moreover, our results demonstrate that the C-terminal half of
cortactin can regulate cell motility independently of the presence
of the N-terminal portion, and this correlates with its ability to
stimulate actin polymerization in vitro. This SH3-mediated
activity is clearly relevant to the function of the full-length
molecule, as full-length cortactin both enhances migration in an
N-WASP-dependent manner and induces N-WASP activation in
pyrene-actin nucleation assays (Fig. 4 and data not shown).
Thus, cortactin, via its SH3 domain, may be important for both
localization and activation of N-WASP.
Clustering of N-WASP can enhance its activation and may be
necessary for its biological effects, and the data presented here
support this hypothesis (Castellano et al., 1999; Hufner et al.,
2001). Specifically, GST-Ct and GST-SH3 proteins were more
potent activators of N-WASP than the untagged proteins.
Although there is no direct evidence for cortactin
multimerization, cortactin is a scaffold protein with many
binding partners and it is likely that clustering of cortactin does
occur in cells because of these interactions. Clustering of other
N-WASP activators, such as activated Cdc42 and Nck, as well
as clustering of the VCA fragment enhances activation
(Castellano et al., 1999; Higgs and Pollard, 2000; Hufner et al.,
2001; Rivera et al., 2004). Thus, although N-WASP can be
activated by several different molecules, in vivo these activators
are likely to do so by both relieving autoinhibition and by
clustering N-WASP.
Previous studies defined a role for cortactin NTA in activation
of the Arp2/3 complex, and here we show a role for the SH3
domain in activation of N-WASP. In addition, while this work
was under review, activation of N-WASP via the cortactin SH3
domain was also reported (Martinez-Quiles et al., 2004). Given
that cortactin and N-WASP binding to Arp2/3 complex have
been shown to be mutually exclusive events, our data suggest a
potential model: cortactin bound to the side of a filament may
first bind and activate N-WASP to initiate daughter filament
formation, then subsequently bind activated Arp2/3 at the branch
point to stabilize the newly branched network (Uruno et al.,
2003). These functions may be important at the leading edge but
could be more significant in other subcellular locations. For
example, although actin turnover at the leading edge is generally
thought to be the driving force in cell migration, vesicle
trafficking can also contribute to this process (Nabi, 1999). N-
WASP is not prominently localized to the leading edge, where
cortactin and Arp2/3 complex can be found (Wu and Parsons,
1993; Weed and Parsons, 1998; Kaksonen et al., 2000; Weed et
al., 2000). Both N-WASP and cortactin, however, are colocalized
in podosomes of v-Src transformed cells, and in filopodia and
the perinuclear region in bradykinin-stimulated 3T3 cells
(Mitzutani et al., 2002; Martinez-Quiles et al., 2004). In addition,
both proteins are found in cytoplasmic puncta associated with
the actin comet tails of trafficking vesicles (Kaksonen et al.,
2000; Taunton et al., 2000; Cao et al., 2003). Furthermore, the
cortactin C-terminus, which promotes cell migration in an N-
WASP-dependent manner, does not localize to the leading edge
but is found in cytoplasmic puncta (data not shown).
Accordingly, cortactin may be important for regulating N-WASP
in such structures, whereas its direct activation of the Arp2/3
complex may be more important in modulating actin dynamics
at the leading edge. At either subcellular location, the SH3
domain also may serve to enhance the function of the NTA
domain through SH3 binding partners such as dynamin and WIP.
Both of these proteins have been shown to modulate the ability
of the NTA domain of cortactin to bind and directly activate the
Arp2/3 complex (Schafer et al., 2002; Kinley et al., 2003).
Although we believe that the ability of cortactin to activate N-
WASP is of importance for basic cellular functions like
migration and vesicle trafficking, it remains unclear whether this
cortactin-N-WASP pathway plays a primary or an accessory role
in these events. This is particularly true given the existence of
other cortactin SH3 domain binding partners that might also
enhance actin polymerization at either the leading edge or on
vesicles to stimulate migration. For example, the interaction of
dynamin with the cortactin SH3 domain is important for the
formation of dorsal membrane ruffles in PDGF-stimulated cells,
which probably contributes to a motile phenotype (McNiven et
al., 2000; Krueger et al., 2003). Furthermore, cortactin and
dynamin are colocalized on PIP5 kinase-induced vesicles and
have been implicated in trafficking (Orth et al., 2002; Cao et al.,
2003). Given that protein and membrane trafficking to and from
the leading edge is important for migration, such interactions
might also be important for cortactin-induced motility (Nabi,
1999).
Regardless of the potential functions of these other binding
partners, our results clearly indicate a role for the cortactin-N-
WASP interaction, as we have shown that: (1) cortactin binds
and activates N-WASP; (2) activation of N-WASP by cortactin
is more robust than its ability to directly activate the Arp2/3
complex; and (3) cortactin-induced migration is dependent upon
N-WASP. As N-WASP is a potent activator of Arp2/3 complex,
activation of N-WASP via cortactin would serve to amplify the
signals transduced by this complex. It is plausible, therefore, that
the cortactin-N-WASP pathway is important in normal actin-
based processes. Moreover, this regulation may be of even
greater significance in tumorigenesis. Cortactin is overexpressed
in head, neck and mammary tumors where its expression
correlates with increased tumor invasiveness (Schuuring et al.,
1992). Thus, given that the enhanced cell migration observed
with overexpression of full-length cortactin is dependent upon
N-WASP, this cortactin-N-WASP pathway may be of great
importance in the invasive phenotypes of cortactin-
overexpressing tumors.
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